Backed by a $24 billion fund, MRFF remains Australia's largest source of medical research financing. It typically supports R&D in areas like brain cancer, dementia, and stem cell therapies. Although up to $1.05 billion could be distributed in 2025–26, only $650 million has been budgeted–highlighting a pressing opportunity for research institutes to act fast.
This established federal program has expanded in 2025 to include emerging sectors like creative tech and agri‑food. Ideal for innovators looking to scale their R&D into overseas markets.
The latest federal budget introduced several high-value programs under the "Build Australia’s Future" initiative:
States continue offering targeted grants. For instance, Victoria’s Industry Development Fund and federal Defence Industry Development Grants (Sovereign Stream) support innovation in manufacturing, especially in defence technology.
The ARC’s National Competitive Grants Program (NCGP) includes high-value Discovery and Linkage grants. These support collaborations and the formation of ARC Centres of Excellence–fostering long-term R&D in areas like synthetic biology and sustainable tech.
Despite reform pressures, CRCs remain indispensable. These focused partnerships between academia, government, and industry continue to deliver strong economic return–estimated at $32.5 billion by 2025.
Use these tools to discover live and forecasted grants:
From multi-billion-dollar federal initiatives to targeted state-level innovation programs, 2025 offers a rich landscape of R&D grant opportunities. Keeping updated on deadlines, eligibility, and sectors can make a significant difference in your funding strategy.
Wondering if you qualify for the R&D Tax Incentive? Let’s find out.